"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -15,543 (-0.2%)","  -1,410 (-5%)","  -2,992 (-2.2%)","    -151 (-7.2%)","  -1,431 (-5.1%)"
"2","50% prioritisation"," -13,656 (-0.1%)","  -1,451 (-5.1%)","  -3,051 (-2.3%)","    -156 (-7.4%)","  -1,474 (-5.3%)"
"3","75% prioritisation"," -12,513 (-0.1%)","  -1,463 (-5.1%)","  -3,063 (-2.3%)","    -157 (-7.5%)","  -1,486 (-5.3%)"
"4","booster at three months (at risk only)"," -96,437 (-1%)","  -7,305 (-25.7%)"," -15,157 (-11.4%)","    -778 (-37%)","  -7,287 (-26.2%)"
"5","additional primary doses"," -23,724 (-0.2%)","  -1,511 (-5.3%)","  -3,351 (-2.5%)","    -158 (-7.5%)","  -1,516 (-5.4%)"
"6","additional booster doses","-123,242 (-1.3%)","  -7,286 (-25.6%)"," -15,806 (-11.9%)","    -756 (-36%)","  -7,181 (-25.8%)"
"7","broaden to <18 pregnant individuals"," -23,724 (-0.2%)","  -1,511 (-5.3%)","  -3,351 (-2.5%)","    -158 (-7.5%)","  -1,516 (-5.4%)"
